1-11 of 11
savor- timi 53 trial
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease

Brian A. Bergmark, Deepak L. Bhatt, Eugene Braunwald, David A. Morrow, Ph. Gabriel Steg, Yared Gurmu, Avivit Cahn, Ofri Mosenzon, Itamar Raz, Erin Bohula, Benjamin M. Scirica
Journal: Diabetes Care
Diabetes Care 2018;41(3):577–585
https://doi.org/10.2337/dc17-1736
Published: 01 December 2017
View article titled, Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease
Open the PDF for Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease in another window
Includes: Supplementary data
Journal Articles

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Ofri Mosenzon, Gil Leibowitz, Deepak L. Bhatt, Avivit Cahn, Boaz Hirshberg, Cheryl Wei, KyungAh Im, Aliza Rozenberg, Ilan Yanuv, Christina Stahre, Kausik K. Ray, Nayyar Iqbal, Eugene Braunwald, Benjamin M. Scirica, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2017;40(1):69–76
https://doi.org/10.2337/dc16-0621
Published: 17 October 2016
View article titled, Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Open the PDF for Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes

Ivan Tkáč, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2017;40(2):284–286
https://doi.org/10.2337/dc15-1707
Published: 22 September 2016
View article titled, Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes
Open the PDF for Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes in another window
Journal Articles

Is the Use of DPP-4 Inhibitors Associated With an Increased Risk for Heart Failure? Lessons From EXAMINE, SAVOR-TIMI 53, and TECOS

Guntram Schernthaner, Avivit Cahn, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2016;39(Supplement_2):S210–S218
https://doi.org/10.2337/dcS15-3009
Published: 16 July 2016
View article titled, Is the Use of DPP-4 Inhibitors Associated With an Increased Risk for Heart Failure? Lessons From EXAMINE, SAVOR-TIMI 53, and TECOS
Open the PDF for Is the Use of DPP-4 Inhibitors Associated With an Increased Risk for Heart Failure? Lessons From EXAMINE, SAVOR-TIMI 53, and TECOS in another window
Journal Articles

Analyses of Results From Cardiovascular Safety Trials With DPP-4 Inhibitors: Cardiovascular Outcomes, Predefined Safety Outcomes, and Pooled Analysis and Meta-analysis

Edoardo Mannucci, Ofri Mosenzon, Angelo Avogaro
Journal: Diabetes Care
Diabetes Care 2016;39(Supplement_2):S196–S204
https://doi.org/10.2337/dcS15-3024
Published: 16 July 2016
View article titled, Analyses of Results From Cardiovascular Safety Trials With DPP-4 Inhibitors: Cardiovascular Outcomes, Predefined Safety Outcomes, and Pooled Analysis and Meta-analysis
Open the PDF for Analyses of Results From Cardiovascular Safety Trials With DPP-4 Inhibitors: Cardiovascular Outcomes, Predefined Safety Outcomes, and Pooled Analysis and Meta-analysis in another window
Journal Articles

DPP-4 Inhibitors and Heart Failure: Some Reassurance, Some Uncertainty

Kristian B. Filion, Samy Suissa
Journal: Diabetes Care
Diabetes Care 2016;39(5):735–737
https://doi.org/10.2337/dci15-0036
Published: 14 April 2016
View article titled, DPP-4 Inhibitors and Heart Failure: Some Reassurance, Some Uncertainty
Open the PDF for DPP-4 Inhibitors and Heart Failure: Some Reassurance, Some Uncertainty in another window
Journal Articles

Association Between Hospitalization for Heart Failure and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes: An Observational Study

Alex Z. Fu, Stephen S. Johnston, Ameen Ghannam, Katherine Tsai, Katherine Cappell, Robert Fowler, Ellen Riehle, Ashley L. Cole, Iftekhar Kalsekar, John Sheehan
Journal: Diabetes Care
Diabetes Care 2016;39(5):726–734
https://doi.org/10.2337/dc15-0764
Published: 06 January 2016
View article titled, Association Between Hospitalization for Heart Failure and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes: An Observational Study
Open the PDF for Association Between Hospitalization for Heart Failure and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes: An Observational Study in another window
Includes: Supplementary data
Journal Articles

Comment on Udell et al. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial. Diabetes Care 2015;38:696–705

Sanjay Kalra, Yashdeep Gupta, Manash P. Baruah, Anu Gupta
Journal: Diabetes Care
Diabetes Care 2015;38(6):e88–e89
https://doi.org/10.2337/dc15-0006
Published: 12 May 2015
View article titled, Comment on Udell et al. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial. Diabetes Care 2015;38:696–705
Open the PDF for Comment on Udell et al. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial. Diabetes Care 2015;38:696–705 in another window
Journal Articles

Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial

Lawrence A. Leiter, Hwee Teoh, Eugene Braunwald, Ofri Mosenzon, Avivit Cahn, K.M. Prasanna Kumar, Alena Smahelova, Boaz Hirshberg, Christina Stahre, Robert Frederich, Francois Bonnici, Benjamin M. Scirica, Deepak L. Bhatt, Itamar Raz, for the SAVOR-TIMI 53 Steering Committee and Investigators
Journal: Diabetes Care
Diabetes Care 2015;38(6):1145–1153
https://doi.org/10.2337/dc14-2868
Published: 10 March 2015
View article titled, Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial
Open the PDF for Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

Jacob A. Udell, Deepak L. Bhatt, Eugene Braunwald, Matthew A. Cavender, Ofri Mosenzon, Ph. Gabriel Steg, Jaime A. Davidson, Jose C. Nicolau, Ramon Corbalan, Boaz Hirshberg, Robert Frederich, KyungAh Im, Amarachi A. Umez-Eronini, Ping He, Darren K. McGuire, Lawrence A. Leiter, Itamar Raz, Benjamin M. Scirica
Journal: Diabetes Care
Diabetes Care 2015;38(4):696–705
https://doi.org/10.2337/dc14-1850
Published: 31 December 2014
View article titled, Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial
Open the PDF for Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin

Itamar Raz, Deepak L. Bhatt, Boaz Hirshberg, Ofri Mosenzon, Benjamin M. Scirica, Amarachi Umez-Eronini, KyungAh Im, Christina Stahre, Alona Buskila, Nayyar Iqbal, Norton Greenberger, Markus M. Lerch
Journal: Diabetes Care
Diabetes Care 2014;37(9):2435–2441
https://doi.org/10.2337/dc13-2546
Published: 07 August 2014
View article titled, Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin
Open the PDF for Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin in another window
Includes: Supplementary data